Nicolle M Gatto (Nicolle Gatto)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Topics

Decision Making

Coronavirus Disease

Top Venues

Clinical pharmacology and therapeutics

Journal of comparative effectiveness research

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Ulka B Campbell, Nicholaas Honig, Nicolle M Gatto
SURF: A Screening tool (for sponsors) to evaluate whether Using real-world data to support an effectiveness claim in an FDA application has Regulatory Feasibility. Clinical pharmacology and therapeutics (2023)
Nicolle M Gatto, Sarah E Vititoe, Emily Rubinstein, Robert F Reynolds, Ulka B Campbell
A Structured Process to Identify Fit-for-Purpose Study Design and Data to Generate Valid and Transparent Real-World Evidence for Regulatory Uses. Clinical pharmacology and therapeutics (2023)
Ashley Jaksa, Patrick J Arena, Nicolle M Gatto
Availability of comparative real-world evidence research in Medicare patients: implications for Centers for Medicare and Medicaid Services drug price negotiations. Journal of comparative effectiveness research (2023)
Nicolle M Gatto, Sarah E Vititoe, Emily Rubinstein, Robert F Reynolds, Ulka B Campbell
A Structured Process to Identify Fit-for-purpose Study Design and Data to Generate Valid and Transparent Real-World Evidence for Regulatory Uses. Clinical pharmacology and therapeutics (2023)
Elizabeth M Garry, Andrew R Weckstein, Kenneth Quinto, Marie C Bradley, Tamar Lasky, Aloka G Chakravarty, Sandy Leonard, Sarah E Vititoe, Imaani J Easthausen, Jeremy A Rassen, Nicolle M Gatto
Categorization of COVID-19 severity to determine mortality risk. Pharmacoepidemiology and drug safety 31 (7) (2022)
Nicolle M Gatto, Shirley V Wang, William Murk, Pattra Mattox, M Alan Brookhart, Andrew Bate, Sebastian G Schneeweiss, Jeremy A Rassen
Visualizations throughout pharmacoepidemiology study planning, implementation, and reporting. Pharmacoepidemiology and drug safety 31 (11) (2022)
Ashley Jaksa, James J Wu, Pall Jonsson, Hans-Georg Eichler, Sarah E Vititoe, Nicolle M Gatto
Organized structure of real-world evidence best practices: moving from fragmented recommendations to comprehensive guidance. Journal of comparative effectiveness research 10 (9) (2021)
Jessica M Franklin, Kueiyu Joshua Lin, Nicolle M Gatto, Jeremy A Rassen, Robert J Glynn, Sebastian G Schneeweiss
Real-World Evidence for Assessing Pharmaceutical Treatments in the Context of COVID-19. Clinical pharmacology and therapeutics 109 (4) (2021)
Nicolle M Gatto, Daniel O Koralek, Michael B Bracken, William T Duggan, Joanna Lem, Sol Klioze, Gary G Koch, Robert A Wise, Roger B Cohen, Neville C Jackson
Lung Cancer-Related Mortality With Inhaled Insulin or a Comparator: Follow-Up Study of patients previously enrolled in Exubera Controlled Clinical Trials (FUSE) Final Results. Diabetes care 42 (9) (2019)